日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation

成纤维细胞活化蛋白靶向放射性药物:从药物设计到临床转化

Wu, Yuxuan; Wang, Xingkai; Sun, Xiaona; Gao, Xin; Zhang, Siqi; Shen, Jieting; Tian, Hao; Chen, Xueyao; Huang, Hongyi; Jiang, Shuo; Zhang, Boyang; Zhang, Yingzi; Lu, Minzi; Zhang, Hailong; Sun, Zhicheng; Liu, Ruping; Zhang, Hong; Zhang, Ming-Rong; Hu, Kuan; Wang, Rui

Enhanced radiotheranostic targeting of integrin α5β1 with PEGylation-enabled peptide multidisplay platform (PEGibody): A strategy for prolonged tumor retention with fast blood clearance.

利用聚乙二醇化肽多展示平台(PEGibody)增强整合素α5β1的放射治疗靶向性:一种延长肿瘤滞留时间并快速清除血液的策略

Zhang Siqi, Ma Xiaohui, Wu Jiang, Shen Jieting, Shi Yuntao, Wang Xingkai, Xie Lin, Sun Xiaona, Wu Yuxuan, Tian Hao, Gao Xin, Chen Xueyao, Huang Hongyi, Chen Lu, Song Xuekai, Hu Qichen, Zhang Hailong, Wang Feng, Jin Zhao-Hui, Zhang Ming-Rong, Wang Rui, Hu Kuan